Role of stem cells in melanoma progression: hopes for a better treatment

References

• Kelly JW, Yeatman JM, Regalia C, Mason G, Henham AP. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med. J. Aust.167, 191–194 (1997).
   PubMed Web of Science ®Google Scholar
• Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front Biosci.11, 1244–1254 (2006).
   PubMed Web of Science ®Google Scholar
• Sharpe G. Skin cancer: prevalence, prevention and treatment. Clin. Med.6, 333–334 (2006).
   PubMed Web of Science ®Google Scholar
• Queirolo P, Acquati M, Kirkwood JM et al. Update: current management issues in malignant melanoma. Melanoma Res.15, 319–324 (2005).
   PubMed Web of Science ®Google Scholar
• Young SE, Martinez SR, Essner R. The role of surgery in treatment of stage IV melanoma. J. Surg. Oncol.94, 344–351 (2006).
   PubMed Web of Science ®Google Scholar
• Mutter N, Stupp R. Temozolomide: a milestone in neuro-oncology and beyond? Expert Rev. Anticancer Ther.6(8), 1187–1204 (2006).
   PubMed Web of Science ®Google Scholar
• Pilla L, Valenti R, Marrari A et al. Vaccination: role in metastatic melanoma. Expert Rev. Anticancer Ther.6(8), 1305–1318 (2006).
   PubMed Web of Science ®Google Scholar
• Herlyn M. Molecular targets in melanoma: strategies and challenges for diagnosis and therapy. Int. J. Cancer118, 523–526 (2006).
   PubMed Web of Science ®Google Scholar
• Meier F, Schittek B, Busch S et al. The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci.10, 2986–3001 (2005).
   PubMed Web of Science ®Google Scholar
• Brose MS, Volpe P, Feldman M et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res.62, 6997–7000 (2002).
   PubMed Web of Science ®Google Scholar
• Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature417, 949–954 (2002).
   PubMed Web of Science ®Google Scholar
• Tsao H, Goel V, Wu H, Yang G, Haluska FG. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Invest. Dermatol.122, 337–341 (2004).
   PubMed Web of Science ®Google Scholar
• Stahl JM, Sharma A, Cheung M et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res.64, 7002–7010 (2004).
   PubMed Web of Science ®Google Scholar
• Flaherty KT. New molecular targets in melanoma. Curr. Opin. Oncol.16, 150–154 (2004).
   PubMed Web of Science ®Google Scholar
• Becker JC, Kirkwood JM, Agarwala SS et al. Molecularly targeted therapy for melanoma: current reality and future options. Cancer107, 2317–2327 (2006).
   PubMed Web of Science ®Google Scholar
• Haass NK, Smalley KS, Herlyn M. The role of altered cell–cell communication in melanoma progression. J. Mol. Histol.35, 309–318 (2004).
   PubMed Web of Science ®Google Scholar
• Hsu MY, Meier FE, Nesbit M et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol.156, 1515–1525 (2000).
   PubMed Web of Science ®Google Scholar
• Hirobe T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment. Cell. Res.18, 2–12 (2005).
   PubMedGoogle Scholar
• Berking C, Takemoto R, Satyamoorthy K et al. Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. Cancer Res.64, 807–811 (2004).
   PubMed Web of Science ®Google Scholar
• Fukunaga-Kalabis M, Martinez G, Liu ZJ et al. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J. Cell. Biol.175, 563–569 (2006).
   PubMed Web of Science ®Google Scholar
• Haass NK, Smalley KS, Li L, Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment. Cell. Res.18, 150–159 (2005).
   PubMedGoogle Scholar
• Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch. Dermatol.139, 1620–1624 (2003).
   PubMedGoogle Scholar
• Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature441, 1068–1074 (2006).
   PubMed Web of Science ®Google Scholar
• Conboy IM, Rando TA. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell3, 397–409 (2002).
   PubMed Web of Science ®Google Scholar
• Cayouette M, Raff M. Asymmetric segregation of Numb: a mechanism for neural specification from Drosophila to mammals. Nat. Neurosci.5, 1265–1269 (2002).
   PubMed Web of Science ®Google Scholar
• Siegrist SE, Doe CQ. Extrinsic cues orient the cell division axis in Drosophila embryonic neuroblasts. Development133, 529–536 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang Z, Zhang C et al. Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat. J. Neurosci.24, 5810–5815 (2004).
   PubMed Web of Science ®Google Scholar
• Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL. The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl Acad. Sci. USA92, 10302–10306 (1995).
   PubMed Web of Science ®Google Scholar
• Nishimura EK, Jordan SA, Oshima H et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature416, 854–860 (2002).
   PubMed Web of Science ®Google Scholar
• Tumbar T, Guasch G, Greco V et al. Defining the epithelial stem cell niche in skin. Science303, 359–363 (2004).
   PubMed Web of Science ®Google Scholar
• Amoh Y, Li L, Katsuoka K, Penman S, Hoffman RM. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc. Natl Acad. Sci. USA102, 5530–5534 (2005).
   PubMed Web of Science ®Google Scholar
• Yu H, Fang D, Kumar SM et al. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am. J. Pathol.168, 1879–1888 (2006).
   PubMed Web of Science ®Google Scholar
• Lang D, Lu MM, Huang L et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature433, 884–887 (2005).
   PubMed Web of Science ®Google Scholar
• Osawa M, Egawa G, Mak SS et al. Molecular characterization of melanocyte stem cells in their niche. Development132, 5589–5599 (2005).
   PubMed Web of Science ®Google Scholar
• Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science307, 720–724 (2005).
   PubMed Web of Science ®Google Scholar
• Mak SS, Moriyama M, Nishioka E, Osawa M, Nishikawa S. Indispensable role of Bcl2 in the development of the melanocyte stem cell. Dev. Biol.291, 144–153 (2006).
   PubMed Web of Science ®Google Scholar
• Moriyama M, Osawa M, Mak SS et al. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J. Cell. Biol.173, 333–339 (2006).
   PubMed Web of Science ®Google Scholar
• Clarke MF, Fuller M. Stem cells and cancer: two faces of eve. Cell124, 1111–1115 (2006).
   PubMed Web of Science ®Google Scholar
• Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea – a paradigm shift. Cancer Res.66, 1883–1890 (2006).
   PubMed Web of Science ®Google Scholar
• Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res.14, 213–222 (1961).
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res.63, 5821–5828 (2003).
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature445, 111–115 (2007).
   PubMed Web of Science ®Google Scholar
• Prince ME, Sivanandan R, Kaczorowski A et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA104, 973–978 (2007).
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature445, 106–110 (2007).
   PubMed Web of Science ®Google Scholar
• Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature367, 645–648 (1994).
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA100, 3983–3988 (2003).
   PubMed Web of Science ®Google Scholar
• Fang D, Nguyen TK, Leishear K et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res.65, 9328–9337 (2005).
   PubMed Web of Science ®Google Scholar
• Grichnik JM, Burch JA, Schulteis RD et al. Melanoma, a tumor based on a mutant stem cell? J. Invest. Dermatol.126, 142–153 (2006).
   PubMed Web of Science ®Google Scholar
• Clarke MF. Oncogenes, self-renewal and cancer. Pathol. Biol. (Paris)54, 109–111 (2006).
   PubMedGoogle Scholar
• Molofsky AV, Pardal R, Iwashita T et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature425, 962–967 (2003).
   PubMed Web of Science ®Google Scholar
• Park IK, Qian D, Kiel M et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature423, 302–305 (2003).
   PubMed Web of Science ®Google Scholar
• Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature423, 255–260 (2003).
   PubMed Web of Science ®Google Scholar
• Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell121, 823–835 (2005).
   PubMed Web of Science ®Google Scholar
• Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature432, 324–331 (2004).
   PubMed Web of Science ®Google Scholar
• Dontu G, Jackson KW, McNicholas E et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res.6, R605–R615 (2004).
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature414, 105–111 (2001).
   PubMed Web of Science ®Google Scholar
• Balint K, Xiao M, Pinnix CC et al. Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression. J. Clin. Invest.115, 3166–3176 (2005).
   PubMed Web of Science ®Google Scholar
• Li L, Xie T. Stem cell niche: structure and function. Annu. Rev. Cell. Dev. Biol.21, 605–631 (2005).
   PubMed Web of Science ®Google Scholar
• Lin H. The stem-cell niche theory: lessons from flies. Nat. Rev. Genet.3, 931–940 (2002).
   PubMed Web of Science ®Google Scholar
• Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature414, 98–104 (2001).
   PubMed Web of Science ®Google Scholar
• Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J.21, 3919–3926 (2002).
   PubMed Web of Science ®Google Scholar
• Scadden DT. The stem-cell niche as an entity of action. Nature441, 1075–1079 (2006).
   PubMed Web of Science ®Google Scholar
• Zhu AJ, Haase I, Watt FM. Signaling via β1 integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro. Proc. Natl Acad. Sci. USA96, 6728–6733 (1999).
   PubMed Web of Science ®Google Scholar
• Stier S, Ko Y, Forkert R et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med.201, 1781–1791 (2005).
   PubMed Web of Science ®Google Scholar
• Garcion E, Halilagic A, Faissner A, ffrench-Constant C. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development131, 3423–3432 (2004).
   PubMed Web of Science ®Google Scholar
• Smalley KS, Brafford PA, Herlyn M. Selective evolutionary pressure from the tissue microenvironment drives tumor progression. Semin. Cancer Biol.15, 451–459 (2005).
   PubMed Web of Science ®Google Scholar
• Chiba S. Notch signaling in stem cell systems. Stem Cells24, 2437–2447 (2006).
   PubMed Web of Science ®Google Scholar
• Pozniak CD, Pleasure SJ. A tale of two signals: Wnt and Hedgehog in dentate neurogenesis. Sci. STKE2006, pe5 (2006).
   PubMedGoogle Scholar
• Rattis FM, Voermans C, Reya T. Wnt signaling in the stem cell niche. Curr. Opin. Hematol.11, 88–94 (2004).
   PubMed Web of Science ®Google Scholar
• Ross J, Li L. Recent advances in understanding extrinsic control of hematopoietic stem cell fate. Curr. Opin. Hematol.13, 237–242 (2006).
   PubMed Web of Science ®Google Scholar
• Lowry WE, Blanpain C, Nowak JA et al. Defining the impact of β-catenin/Tcf transactivation on epithelial stem cells. Genes Dev.19, 1596–1611 (2005).
   PubMed Web of Science ®Google Scholar
• Silva-Vargas V, Lo Celso C, Giangreco A et al. β-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev. Cell9, 121–131 (2005).
   PubMed Web of Science ®Google Scholar
• Sun TT, Cotsarelis G, Lavker RM. Hair follicular stem cells: the bulge-activation hypothesis. J. Invest. Dermatol.96, 77S–78S (1991).
   Web of Science ®Google Scholar
• Smalley KS, Haass NK, Brafford PA et al. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol. Cancer Ther.5, 1136–1144 (2006).
   PubMed Web of Science ®Google Scholar
• Fan X, Matsui W, Khaki L et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res.66, 7445–7452 (2006).
   PubMed Web of Science ®Google Scholar